Cancer Patients With Medical Marijuana Cards Less Likely to Receive Excess Antiemetics, Arkansas Study Finds
A study of cancer patients found medical marijuana cardholder antiemetic overuse was significantly lower during chemotherapy. This suggests a potential role for cannabis in reducing excess antiemetic prescriptions. Further research is needed to confirm…
Cannabis Prescriptions Did Not Lower Opioid Use in GI Cancer Patients Starting Chemotherapy
A large study of gastrointestinal cancer patients examined cannabinoid prescribing oncology opioid use GI cancer patterns after chemotherapy initiation. Only 2.4% received FDA-approved cannabinoid prescriptions, and those patients were more likely to use…
Cannabinoids and Opioid Use in GI Cancer Chemotherapy: Large EHR Study
This study analyzes cannabinoid prescribing in oncology among gastrointestinal cancer patients starting chemotherapy. Only 2.4% received FDA-approved cannabinoids, with higher opioid co-prescribing observed. The findings highlight prescribing patterns…
Investigating the Synergistic Effect of the Cannabis Extract PHEC-66 and Chemotherapeutic Agents on Human Melanoma Cells.
Melanoma is a malignant neoplasm that originates from melanocytes. It continues to pose a significant challenge in oncology due to its aggressive nature and ...
Medicinal Cannabis to Reduce Chemotherapy Side Effects | Adelaide University
Adelaide University is conducting clinical trials on medicinal cannabis chemotherapy nausea relief. This research targets nausea, vomiting, and appetite loss from chemotherapy. Medicinal cannabis chemotherapy nausea relief offers hope where standard…
Hawaii Senators Pass Resolutions Seeking Federal Medical Marijuana Exemption From DEA
Hawaii's push for a federal medical marijuana exemption aims to reduce DEA enforcement barriers for clinicians and patients. This resolution could clarify legal ambiguities and support evidence-based cannabis prescribing. The focus on federal exemption…
Unraveling Endocannabinoid Signaling Pathways in Cisplatin-Induced Ototoxicity
Cisplatin-induced ototoxicity is a detrimental side effect of chemotherapy leading to hearing loss, for which no treatments are currently available. This study reveals the presence of endocannabinoid signaling pathways in auditory hair cells affected by…
Investigating the Synergistic Effect of Cannabis Extract PHEC-66 and Chemotherapy on Melanoma
This study explores cannabis chemotherapy interactions melanoma by testing the cannabis extract PHEC-66 with chemotherapy agents on melanoma cells. Results show potential additive and antagonistic effects depending on the drug. Understanding cannabis…
Delta-9-Tetrahydrocannabinol alleviates chemotherapy-induced weight loss but not colitis
Delta-9-tetrahydrocannabinol weight loss effects were studied in a preclinical model showing benefits against chemotherapy-induced weight loss. This research highlights THC's potential in managing weight loss during chemotherapy. However,…
Targeting Molecular Pathways in Neuropathic Cancer Pain: From Mechanisms to Novel Therapeutics
Neuropathic cancer pain management remains a significant clinical challenge due to its complex molecular pathways. Emerging therapeutics targeting these pathways offer new hope for relief. This review highlights advances in neuropathic cancer pain…